Navigation Links
BioConvergence® Prepares to Present Next Webinar “Shipping Lane Qualification: A Risk-Based, Efficient Approach”
Date:8/7/2014

Bloomington, IN (PRWEB) August 07, 2014

BioConvergence prepares to host its next webinar, “Shipping Lane Qualification: A Risk-Based, Efficient Approach”, on August 13th at 1:00 p.m. EDT. The presenters, Travis Hudson and Carl Rush, have developed this webinar to include discussion of the costs and benefits of conducting shipping lane qualification studies, potential challenges that can be encountered, and examples of how BioConvergence overcame those challenges when performing this type of shipping lane qualification.

When discussing why they chose this topic, Hudson states, “More often than not, shipping lane qualifications are performed by large commercial firms with large amounts of product traversing repeated lanes. We wanted to show that development material faces the same risks as commercial material in the supply chain and that a study can be performed in a way that creates value, while at the same time conserving resources.”

The webinar is targeted towards small- to mid-size pharmaceutical companies. Employees responsible for maintaining product security and viability for temperature-controlled development materials through the supply chain should attend. Also, personnel interested in learning when it is appropriate to perform a shipping lane qualification should attend. Hudson and Rush will illustrate how to design and execute a shipping lane qualification in a way that creates value and mitigates risk.

Another benefit of attending the webinar is the availability of a shipping lane qualification risk-assessment questionnaire for companies to implement in their own decision-making processes. All webinar attendees will be entered into a drawing for a $50 Amazon gift card.

To learn more about performing a shipping lane qualification, consult Hudson’s blog post: “3 Steps to Determine Need for Shipping Lane Qualification.”

Does this topic interest you? Could it benefit your company? Register for the webinar today. Space is limited.

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, BioConvergence has over 50 employees with more than five centuries’ worth of combined experience in the pharmaceutical industry. The unique E-Transparency® System provides transparency and flexibility to clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12079904.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Rock Spa® at Seminole Hard Rock Hotel & Casino Tampa Prepares for Expansion
2. Jared “JJ” Woods Prepares for American Ninja Warrior City Finals
3. Qualidigm Prepares to Launch Innovative Video Series on Managing Chronic Obstructive Pulmonary Disease
4. Study: Four Habits Model prepares pediatric nurses for emotionally difficult discussions
5. AvreaFoster Prepares to Move to Ross Tower
6. Thailand Prepares to Illuminate for the 2013 Loi Krathong Festival
7. BPI Sports Prepares to Launch 1MR VORTEX™ Pre-Workout
8. TreatmentUSA.com Prepares to Celebrate 6 Years of Assisting People Find Recovery from Addiction
9. Nationwide Title Clearing, Inc. Prepares for “Light the Night Walk” for Cancer Fundraising
10. The 54th National Dialogues on Behavioral Health Conference Prepares Behavioral Health Organizations for Evolving Markets on Eve of ACA Implementation
11. Colorado Springs Prepares for Actors, Models and Talent for Christ Auditions on Saturday, September 28th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: